Ultragenyx Pharmaceutical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RARE and other ETFs, options, and stocks.About RARE
Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza.
CEOEmil D. Kakkis
CEOEmil D. Kakkis
Employees1,294
Employees1,294
HeadquartersNovato, California
HeadquartersNovato, California
Founded2010
Founded2010
Employees1,294
Employees1,294
RARE Key Statistics
Market cap2.49B
Market cap2.49B
Price-Earnings ratio-4.66
Price-Earnings ratio-4.66
Dividend yield—
Dividend yield—
Average volume3.86M
Average volume3.86M
High today$27.89
High today$27.89
Low today$26.00
Low today$26.00
Open price$27.46
Open price$27.46
Volume3.90M
Volume3.90M
52 Week high$60.37
52 Week high$60.37
52 Week low$26.00
52 Week low$26.00
RARE News
Benzinga 4d
FDA Delays Approval For Ultragenyx's Gene Therapy, But Not A Dealbreaker, Says AnalystThe U.S. Food and Drug Administration issued on Friday a Complete Response Letter for Ultragenyx Pharmaceutical Inc.’s RARE Biologics License Application (BLA)...
Benzinga 5d
Ultragenyx Pharmaceutical, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market SessionU.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Monday. Shares of Ultragenyx Pharmaceutical Inc. RARE fell sharpl...
Analyst ratings
95%
of 19 ratingsBuy
94.7%
Hold
5.3%
Sell
0%
People also own
Based on the portfolios of people who own RARE. This list is generated using Robinhood data, and it’s not a recommendation.